Clinical Trial Update: Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery [NA]

View source ↗

Summary

The clinical trial investigating secretin-enhanced MRCP and pancreatic function after pancreatic cancer surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Columbia University | Conditions: Pancreatic Cancer | NA | Status: WITHDRAWN